Inclusion Criteria:

- male and female patients;

- >=18 years of age;

- anemia and prescribed treatment with NeoRecormon;

- confirmed diagnosis of a solid or lymphoid hematologic malignancy;

- receiving or scheduled to receive chemotherapy;

- life expectancy of >=6 months.

Exclusion Criteria:

- anemia after bleeding, hemolytic anemia, megaloblastic anemia, anemia in chronic
kidney failure, lever and endocrinology diseases;

- contraindications to NeoRecormon;

- administration of NeoRecormon during chemotherapy (e.g. on the third day after
chemotherapy cycle start);

- bleeding within one month before and/or during study;

- severe infection within one month before and/or during study;

- inability of patient to fill the questionnaires in.